LIFTiD represents a growing trend in a new generation of consumer tDCS devices where these devices are typically optimized to facilitate and/or enhance a certain task that a user is performing, enabling the user to not only be confident in the efficacy of the stimulation they are obtaining, but to also not worry about precise positioning of the electrodes on the head
In a recent podcast featured on techstination, Ken Davidoff of RPW Technology introduces Liftid—a brand new, consumer grade tDCS wearable devices promising to take stimulating the brain to the next level.
One of the first things you learn about Transcranial Direct Current Stimulation (tDCS) is that you put the anode electrode over the part of the brain you wish to excite and the cathode electrode over the part of the brain you wish to inhibit.
An article was recently published on Nature giving a great overview on the current state of transcranial direct current stimulation (tDCS)—along with the context surrounding neuromodulation in general. An important point this piece brings up toward the end—is the free-for-all nature of the current state of marketing for tDCS.
A recent article in the journal Cell, suggested Interferential Stimulation with electrodes on the scalp can activate the hippocampus.
A recent article published defines all the language and terminology used in tES (transcranial electrical stimulation)—including what exactly classifies tDCS as tDCS.
In a recent study published at the University of São Paulo, researchers aimed to evaluate the ability of tDCS to improve balance in different populations by conducting a meta-analysis on existing literature.
Problems with associative memory is common in diseases where degeneration of brain tissue occurs. It is also known that proper theta-band brain wave oscillations within the neural networks of the brain associated with associative memory performance is key to successfully encoding memory.
In a study now made freely accessible online, Dr. Marom Bikson’s lab at the City College of New York attempted to elucidate the underlying mechanism behind the apparent heating effect tDCS had on the area of stimulation.
A recent study by Carvalho et al., titled “Home-Based Transcranial Direct Current Stimulation Device Development: An Updated Protocol Used at Home in Healthy Subjects and Fibromyalgia Patients” explores the potential use of at-home tDCS for treating fibromyalgia.
The Food and Drug Administration (FDA) recently announced the clearance of NeuroSigma’s Monarch external Trigeminal Nerve Stimulation (eTNS) system for treating children with ADHD.